Fisher & Paykel Healthcare Corporation Limited (ASX: FPH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Fisher & Paykel Healthcare Corporation Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)
Latest News
Share Gainers
Here are the top 10 ASX 200 shares today
Earnings Results
Fisher & Paykel shares surge 8% on half-year results
Share Gainers
Here are the top 10 ASX 200 shares today
Share Market News
CSL, Telix and more: Key reporting dates for 10 ASX 200 healthcare stocks in August
Share Market News
Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors
Healthcare Shares
Why does Macquarie think Fisher & Paykel shares are a buy?
Share Gainers
Here are the top 10 ASX 200 shares today
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Fallers
Why ALS, Fisher & Paykel Healthcare, IPD, and Predictive Discovery shares are falling today
Healthcare Shares
Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result?
Share Gainers
Here are the top 10 ASX 200 shares today
Frequently Asked Questions
-
Yes, Fisher & Paykel Healthcare has historically paid two unfranked shareholder dividends a year.
-
Fisher & Paykel Healthcare generally pays its shareholder dividends in July and December.
-
Yes, Fisher & Paykel Healthcare has a dividend reinvestment plan which allows eligible shareholders in New Zealand, Australia, and the United Kingdom to reinvest all or part of their cash dividends in additional ordinary shares free of brokerage fees.
-
Yes, Fisher & Paykel Healthcare Corporation Ltd is listed on the ASX and the New Zealand Exchange.
-
Fisher & Paykel Healthcare Corporation Ltd listed on the ASX on 21 November 2001.
FPH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) is among the world's major designers and manufacturers of respiratory devices. These include products and systems covering in-hospital respiratory care, acute care, and the treatment of obstructive sleep apnea.
The New Zealand-based company earns around 42% of its revenue from the US market and around 30% in Europe. Its hospital products account for about 65% of its revenue with its at-home sleep apnea devices and other respiratory aids accounting for the rest.
Fisher & Paykel invests more than 10% of its operating revenue into its own research and development and has thousands of patents and pending applications. The company has manufacturing facilities in both New Zealand and Mexico.
